OMNIPAQUE- iohexol injection, solution Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

omnipaque- iohexol injection, solution

ge healthcare inc. - iohexol (unii: 4419t9mx03) (iohexol - unii:4419t9mx03) - iodine 300 mg in 1 ml - omnipaque 300 is indicated for intrathecal administration in adults including myelography (lumbar, thoracic, cervical, total columnar) and in contrast enhancement for computerized tomography (myelography, cisternography, ventriculography). omnipaque should not be administered to patients with a known hypersensitivity to iohexol. myelography should not be performed in the presence of significant local or systemic infection where bacteremia is likely. intrathecal administration of corticosteroids with omnipaque is contraindicated. because of the possibility of overdosage, immediate repeat myelography in the event of technical failure is contraindicated (see dosage and administration). omnipaque 350 is indicated in adults for angiocardiography (ventriculography, selective coronary arteriography), aortography including studies of the aortic root, aortic arch, ascending aorta, abdominal aorta and its branches, intravenous digital subtraction angiography of the head, neck, abdominal, renal and peripheral vessels, p

OMNIPAQUE- iohexol injection, solution Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

omnipaque- iohexol injection, solution

ge healthcare inc. - iohexol (unii: 4419t9mx03) (iohexol - unii:4419t9mx03) - omnipaque 300 is indicated for intrathecal administration in adults including myelography (lumbar, thoracic, cervical, total columnar) and in contrast enhancement for computerized tomography (myelography, cisternography, ventriculography). omnipaque should not be administered to patients with a known hypersensitivity to iohexol. myelography should not be performed in the presence of significant local or systemic infection where bacteremia is likely. intrathecal administration of corticosteroids with omnipaque is contraindicated. because of the possibility of overdosage, immediate repeat myelography in the event of technical failure is contraindicated (see dosage and administration). omnipaque 350 is indicated in adults for angiocardiography (ventriculography, selective coronary arteriography), aortography including studies of the aortic root, aortic arch, ascending aorta, abdominal aorta and its branches, intravenous digital subtraction angiography of the head, neck, abdominal, renal and peripheral vessels

Omnipaque Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

omnipaque

ge healthcare limited - iohexol 518 mg/ml equivalent to 240 mg i/ml - solution for injection - 240 mg i/ ml - active: iohexol 518 mg/ml equivalent to 240 mg i/ml excipient: sodium calcium edetate trometamol water for injection - this medicinal product is for diagnostic use only. intravscular omnipaque is indicated in adults for angiography, excretory urographyand ct-enhancement. in children, omnipaque is indicated for angiography and urography. intrathecal omnipaque is indicated for lumbar, thoracic, cervical and total columnar myelography and computed tomography of the cns in adults and children.

Omnipaque Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

omnipaque

ge healthcare limited - iohexol 647 mg/ml equivalent to 300 mg i/ml - solution for injection - 300 mg i/ ml - active: iohexol 647 mg/ml equivalent to 300 mg i/ml excipient: sodium calcium edetate trometamol water for injection - this medicinal product is for diagnostic use only. intravscular omnipaque is indicated in adults for angiography, excretory urographyand ct-enhancement. in children, omnipaque is indicated for angiography and urography. intrathecal omnipaque is indicated for lumbar, thoracic, cervical and total columnar myelography and computed tomography of the cns in adults and children.

Omnipaque Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

omnipaque

ge healthcare limited - iohexol 755 mg/ml equivalent to 350 mg i/ml - solution for injection - 350 mg i/ ml - active: iohexol 755 mg/ml equivalent to 350 mg i/ml excipient: sodium calcium edetate trometamol water for injection - this medicinal product is for diagnostic use only. intravscular omnipaque is indicated in adults for angiography, excretory urographyand ct-enhancement. in children, omnipaque is indicated for angiography and urography. intrathecal omnipaque is indicated for lumbar, thoracic, cervical and total columnar myelography and computed tomography of the cns in adults and children.

Vesomni 6 mg/0.4 mg modified release tablets Irlanda - engleză - HPRA (Health Products Regulatory Authority)

vesomni 6 mg/0.4 mg modified release tablets

lexon (uk) ltd - solifenacin succinate; tamsulosin hydrochloride - modified-release tablet - 6/0.4 milligram(s) - alpha-adrenoreceptor antagonists; tamsulosin and solifenacin

Vesomni 6 mg/0.4 mg modified-release tablets Irlanda - engleză - HPRA (Health Products Regulatory Authority)

vesomni 6 mg/0.4 mg modified-release tablets

lexon pharmaceuticals (ireland) limited - solifenacin succinate; tamsulosin hydrochloride - modified-release tablet - 6/0.4 milligram(s) - alpha-adrenoreceptor antagonists; tamsulosin and solifenacin

Omnic Ocas 0.4 prolonged release film-coated Tablets Malta - engleză - Medicines Authority

omnic ocas 0.4 prolonged release film-coated tablets

astellas pharma europe b.v. - tamsulosin hydrochloride - film-coated tablet - tamsulosin hydrochloride 0.4 milligram(s) - urologicals

NUTRA-LIFE MENO-LIFE DAY + NIGHT Australia - engleză - Department of Health (Therapeutic Goods Administration)

nutra-life meno-life day + night

vitaco health australia pty ltd - actaea racemosa,angelica polymorpha,calcium citrate tetrahydrate,eleutherococcus senticosus,glycine max,heavy magnesium oxide,hypericum perforatum,passiflora incarnata,trifolium pratense,valeriana officinalis,vitex agnus-castus -